MedTrace Logo

Corneal Confocal Microscopy in Patients With Type 1 Diabetes

NCT03045250 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2018-09-04

No results posted yet for this study

Summary

Assessing the use of corneal confocal microscopy to evaluate for early neuropathy changes in subjects with Type 1 Diabetes.

Conditions

  • Diabetic Neuropathies

Interventions

DEVICE

Corneal confocal microscopy

Confocal miscroscopy will be used to assess corneal nerve changes due to hyperglycemia.

PROCEDURE

Skin biopsy

Skin biopsy will be used to assess the appearance of nerve fibers in subjects with type 1 diabetes.

PROCEDURE

Nerve conduction study

Nerve conduction studies will be use to assess for neuropathy.

OTHER

Blood draw

Subjects will undergo a one time blood draw for biomarkers.

Sponsors & Collaborators

  • Albert Einstein College of Medicine

    lead OTHER

Principal Investigators

  • Lisa Underland, MD · Montefiore Medical Center at Albert Einstein College of Medicine

Study Design

Allocation
NON_RANDOMIZED
Purpose
SCREENING
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
35 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-08-01
Primary Completion
2020-02-01
Completion
2020-02-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03045250 on ClinicalTrials.gov